On October 17 and 18, the annual meeting of the GenRisk strategic action was held in Pamplona, in which researchers from 14 groups of the CIBERESP institution participated.
Initially, the first year follow-up of the GenRisk-Cancer project, funded by the Scientific Foundation of the Spanish Association Against Cancer (AECC), has been presented. The GenRisk-Cancer project, whose principal investigator is Víctor Moreno, aims to improve cancer prevention through personalized strategies. Through the analysis of genetic and lifestyle data, it is intended to develop risk models and define improvements in screening strategies for cancer prevention. During the first year, 6,375 DNA samples have been collected, with which a complete genome analysis will be performed, to combine the data with another 2,463 of which these data are already available. Together, it will be the largest study with genetic data in cancer patients in Spain.
In addition to commenting on the evolution of the GenRisk-Cancer project, there has also been a session on genomic studies in diseases other than cancer, in which Dolores Corella and Cristina Razquin have made two presentations on the PREDIMED trial.
On the second day, a session on large cohorts with genomic data was held: Klaudia Walter, from the Wellcome Sanger Institute, made a presentation on multidimensional cohorts in precision medicine; Rafael de Cid has presented the GCAT project, a study that aims to understand the genetic and environmental factors that influence the onset of chronic diseases; Finally, Eric Duell has talked about the PanScan-PanC4 project, a consortium of various studies, whose researchers intend to learn about the etiology and natural history of pancreatic cancer.
There has also been room for an educational workshop on the exploitation of omic data in public databases, taught by Juan Ramón González, a researcher at ISGlobal.
Finally, the participants have reflected on the next steps to take in the strategic GenRisk action.